U.S. market Open. Closes in 3 hours 3 minutes

NARI | Inari Medical, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for NARI we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is weak.

Valuation (31%)

Company Industry
P/E Ratio (TTM) -44.53 47.85
PEG Ratio (TTM) 0.31 -0.77
P/S Ratio (TTM) 4.65 6.10
P/B Ratio (TTM) 6.00 6.12
P/FCF Ratio (TTM) 150.60 42.18
Price to 5YR AVG Earnings Ratio 38,672.57 59.80
Price to 5YR AVG FCF Ratio 2,116.25 34.34

Profitability (0%)

Company Industry
ROA (TTM) -8.48% 5.29%
ROE (TTM) -12.76% 27.69%
Net Profit Margin (TTM) -10.42% 7.92%
ROIC 5YR AVG -0.55% 6.68%

Growth (83%)

4QTR AVG 3YR AVG 5YR AVG
EPS -158.02% 405.71% 187.38%
Revenue 5.24% 306.73% 197.47%
Net Income -161.01% 291.87% 114.52%
Cash Flow 8.35% 475.46% 325.74%

Health (44%)

Company Industry
Current Ratio (TTM) 1.80 2.88
Quick Ratio (TTM) 1.45 2.15
D/E Ratio (TTM) 0.08 0.62
Interest Coverage (TTM) -121.13 23.32
Piotroski F-Score 3 6
Altman Z-Score 6.76 7.57
LTL to 5YR AVG FCF 25.23 3.50
Shares Outstanding Growth 5YR AVG 12.22% 1.64%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙